TheStreet upgraded shares of Misonix (NASDAQ:MSON) from a d+ rating to a c rating in a research note released on Tuesday, TheStreetRatingsTable reports.
MSON opened at $19.04 on Tuesday. The company has a market cap of $331.14 million, a P/E ratio of -13.04 and a beta of 1.48. The company has a quick ratio of 2.43, a current ratio of 3.13 and a debt-to-equity ratio of 0.26. The firm’s 50-day moving average price is $18.80 and its 200-day moving average price is $14.57. Misonix has a 52-week low of $9.06 and a 52-week high of $20.71.
Misonix (NASDAQ:MSON) last released its earnings results on Thursday, February 4th. The medical equipment provider reported ($0.07) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.22. The company had revenue of $18.26 million for the quarter. Misonix had a negative net margin of 35.03% and a negative return on equity of 16.94%.
Institutional investors have recently bought and sold shares of the stock. Nuveen Asset Management LLC raised its position in Misonix by 1.4% during the fourth quarter. Nuveen Asset Management LLC now owns 63,543 shares of the medical equipment provider’s stock valued at $794,000 after acquiring an additional 867 shares in the last quarter. California Public Employees Retirement System grew its stake in shares of Misonix by 4.4% during the 3rd quarter. California Public Employees Retirement System now owns 30,600 shares of the medical equipment provider’s stock worth $359,000 after purchasing an additional 1,300 shares during the period. Rhumbline Advisers grew its stake in shares of Misonix by 12.6% during the 4th quarter. Rhumbline Advisers now owns 13,351 shares of the medical equipment provider’s stock worth $167,000 after purchasing an additional 1,495 shares during the period. Mesirow Financial Investment Management Inc. increased its holdings in shares of Misonix by 7.4% during the 4th quarter. Mesirow Financial Investment Management Inc. now owns 24,835 shares of the medical equipment provider’s stock valued at $310,000 after purchasing an additional 1,719 shares in the last quarter. Finally, Citigroup Inc. lifted its stake in shares of Misonix by 303.1% in the 4th quarter. Citigroup Inc. now owns 2,330 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 1,752 shares during the period. 41.19% of the stock is currently owned by hedge funds and other institutional investors.
Misonix, Inc, together with its subsidiaries, designs, develops, manufactures, and markets minimally invasive surgical ultrasonic medical devices in the United States and internationally. The company's products include BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells.
See Also: QQQ ETF
Receive News & Ratings for Misonix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Misonix and related companies with MarketBeat.com's FREE daily email newsletter.